Molecular Characteristics and Antimicrobial Susceptibility Profiles of bla_KPC-Producing Escherichia Coli Isolated from a Teaching Hospital in Shanghai, China

References

• Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123–140. doi:10.1038/nrmicro818
   PubMed Web of Science ®Google Scholar
• Roer L, Aarestrup FM, Hasman H, Gourse RL. The ecoki type I restriction-modification system in Escherichia coli affects but is not an absolute barrier for conjugation. J Bacteriol. 2015;197(2):337–342. doi:10.1128/JB.02418-14
   PubMed Web of Science ®Google Scholar
• Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18(5):263–272. doi:10.1016/j.molmed.2012.03.003
   PubMed Web of Science ®Google Scholar
• Potter RF, Aw D, Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist Updat. 2016;29:30–46. doi:10.1016/j.drup.2016.09.002
   PubMed Web of Science ®Google Scholar
• Martínez-Martínez L, González-López JJ. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology. Enfermedades Infecciosas y Microbiologia Clinica. 2014;32(Suppl 4):4–9. doi:10.1016/S0213-005X(14)70168-5
   PubMedGoogle Scholar
• Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–1161. doi:10.1128/AAC.45.4.1151-1161.2001
   PubMed Web of Science ®Google Scholar
• Papp-Wallace KM, Bethel CR, Distler AM, Kasuboski C, Taracila M, Bonomo RA. Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase. Antimicrob Agents Chemother. 2010;54(2):890–897. doi:10.1128/AAC.00693-09
   PubMed Web of Science ®Google Scholar
• Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 2014;22(12):686–696. doi:10.1016/j.tim.2014.09.003
   PubMed Web of Science ®Google Scholar
• Zhang R, Liu L, Zhou H, et al. Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine. 2017;19:98–106. doi:10.1016/j.ebiom.2017.04.032
   PubMed Web of Science ®Google Scholar
• Marimuthu K, Venkatachalam I, Khong WX, et al. Clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae among adult inpatients in Singapore. Arch Clin Infect Dis. 2017;64(suppl_2):S68–s75.
   Google Scholar
• CLSI. Performance standards for antimicrobial susceptibility testing: twenty-ninth edition; 2019:M100.
   Google Scholar
• European Committee on Antimicrobial Susceptibility Testing.EUCAST clinical breakpoint table. Available from: https://www.eucast.org/clinical_breakpoints/.
   Google Scholar
• Petty NK, Ben Zakour NL, Stanton-Cook M, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA. 2014;111(15):5694–5699. doi:10.1073/pnas.1322678111
   PubMed Web of Science ®Google Scholar
• The Review on Antimicrobial Resistance. Chaired by Jim O’Neill;2016.
   Google Scholar
• De Oliveira DMP, Forde BM, Kidd TJ, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3): doi:10.1128/CMR.00181-19
   PubMed Web of Science ®Google Scholar
• Bonomo RA, Burd EM, Conly J, et al. Carbapenemase-producing organisms: a global scourge. Arch Clin Infect Dis. 2018;66(8):1290–1297. doi:10.1093/cid/cix893
   Google Scholar
• Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27(3):543–574. doi:10.1128/CMR.00125-13
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Quinn JP. The spread of Klebsiella pneumoniae carbapenemases: a tale of strains, plasmids, and transposons. Arch Clin Infect Dis. 2009;49(11):1739–1741. doi:10.1086/648078
   Google Scholar
• Tang Y, Fu P, Zhou Y, et al. Absence of the type I-E CRISPR-cas system in Klebsiella pneumoniae clonal complex 258 is associated with dissemination of IncF epidemic resistance plasmids in this clonal complex. J Antimicrob Chemother. 2020;75(4):890–895. doi:10.1093/jac/dkz538
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tang Y, Fu P, et al. The type I-E CRISPR-cas system influences the acquisition of bla(KPC)-IncF plasmid in Klebsiella pneumonia. Emerging Microbes Infect. 2020;9(1):1011–1022. doi:10.1080/22221751.2020.1763209
   PubMed Web of Science ®Google Scholar
• Li D, Li P, Peng M, et al. Transmission barrier of the blaKPC plasmid mediated by type I restriction-modification systems in Escherichia coli. J Antimicrob Chemother. 2022;77(4):952–956. doi:10.1093/jac/dkab489
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):252–275. doi:10.1093/femsre/fux013
   PubMed Web of Science ®Google Scholar
• Weingarten RA, Johnson RC, Conlan S, et al. Genomic analysis of hospital plumbing reveals diverse reservoir of bacterial plasmids conferring carbapenem resistance. mBio. 2018;9(1): doi:10.1128/mBio.02011-17
   PubMed Web of Science ®Google Scholar
• Hazen TH, Mettus R, McElheny CL, et al. Diversity among bla(KPC)-containing plasmids in Escherichia coli and other bacterial species isolated from the same patients. Sci Rep. 2018;8(1):10291. doi:10.1038/s41598-018-28085-7
   PubMedGoogle Scholar
• Gomez-Simmonds A, Annavajhala MK, Tang N, et al. Population structure of blaKPC-harbouring IncN plasmids at a New York city medical centre and evidence for multi-species horizontal transmission. J Antimicrob Chemother. 2022;77(7):1873–1882. doi:10.1093/jac/dkac114
   PubMed Web of Science ®Google Scholar
• Goldfarb T, Sberro H, Weinstock E, et al. BREX is a novel phage resistance system widespread in microbial genomes. EMBO J. 2015;34(2):169–183. doi:10.15252/embj.201489455
   PubMed Web of Science ®Google Scholar